Truist Securities reiterates Tesla stock Hold rating at $400 target By Investing.com

Tesla posted a modest Q1 revenue and EPS beat, with EPS at $0.41 versus $0.36 expected and revenue of $22.39 billion versus $22.28 billion, but did not issue Q2 guidance. Management raised capex to $25 billion from $20 billion, implying negative free cash flow this year despite $6.2 billion in trailing 12-month levered free cash flow and 18% gross margins. Truist kept a Hold rating and $400 target, while other analysts cited autonomous vehicle and robotics catalysts.

Analysis

The key market issue is not the earnings beat; it is the implied rerating of Tesla from a cyclical auto manufacturer to a capital-intensive option on AI and autonomy. Higher capex pushes reported free cash flow toward zero or negative in the near term, which removes the main valuation support for investors who were underwriting TSLA as a cash compounder. That makes the stock more duration-sensitive: if the market’s discount rate stays high, the multiple can compress even if operational execution remains solid.

Second-order effects matter more than the headline spend. Incremental capex into autonomy, compute, and robotics likely deepens Tesla’s dependence on external semiconductor, foundry, networking, and power infrastructure vendors, while reducing relevance of delivery cadence and other auto KPIs. That shifts the competitive battleground toward companies that can monetize picks-and-shovels exposure to AI buildout without the execution risk of a consumer hardware platform. It also raises the bar for rivals in EVs, because Tesla can use the balance sheet and brand to subsidize a longer commercialization window.

The consensus is probably underestimating how much of the near-term upside is already in the stock. When a company trades on optionality, capex acceleration is only bullish if the market believes the payoff window is within 12-24 months; otherwise it reads as a cash burn increase. The catalyst path is binary: progress on robotaxi/autonomy milestones or meaningful inference/robotics revenue can re-rate the stock, but any delay in monetization makes the current valuation vulnerable to a 10-20% drawdown as investors refocus on negative FCF and lack of guidance.

Key Decisions for Investors

• Trim or hedge outright TSLA longs into strength over the next 1-3 weeks; the near-term risk/reward is skewed against multiple expansion while free cash flow turns negative. Best expression: buy 1-3 month puts or finance them by selling upside calls against existing stock.
• For investors wanting AI exposure, rotate from TSLA beta into suppliers with clearer monetization and lower execution risk over the next 6-12 months; long the picks-and-shovels beneficiaries and avoid paying up for the platform optionality premium.
• Pair trade: short TSLA / long a basket of AI infrastructure beneficiaries on any post-earnings rally; thesis is that capex acceleration benefits compute/networking names immediately, while Tesla’s payoff is delayed and less certain. Use a 3-6 month horizon with a target of mean reversion in the valuation spread.
• If maintaining a TSLA core position, hedge event risk around future autonomy/robotaxi announcements with defined-risk call spreads rather than naked long stock; the stock can move sharply on headlines, but the downside from a missed commercialization timeline is larger over the next 2-4 quarters.
• Watch for any signs that capex converts into operating leverage by year-end; if not, reduce exposure aggressively because the market will likely punish a second consecutive period of negative FCF without a visible revenue bridge.